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ABSTRACT: In order to serve increasing numbers of Medicaid beneficiaries, particularly 
during an economic recession, states must find ways to maximize the impact of available 
funds. Some states are identifying new ways of organizing, financing, and delivering 
health care in order to lower costs without sacrificing quality of care or enrollment capac-
ity. An important tool for helping policymakers design such “value-added” strategies is 
return-on-investment (ROI) analysis. ROI forecasting has long been used to inform the 
allocation of limited resources in the private sector. This brief outlines what ROI can do, 
and in a few cases has already done, in the public sector, to improve quality and control 
costs in Medicaid.
                    
OVERVIEw
Medicaid provides care to more than 67 million Americans at a combined cost to 
the federal and state governments exceeding $364 billion.1 The sheer size of this 
publicly-funded program and its role in serving millions with significant health 
care needs suggests a unique opportunity for Medicaid to use its purchasing 
power to drive improvements in the quality and cost-effectiveness of care. This 
opportunity becomes even more pressing in economic downturns, as Medicaid 
outlays can represent up to 33 percent of a state’s total expenditures—making 
the program a huge target for state policymakers needing to balance their bud-
gets.2 During recessions, Medicaid enrollment increases and the demand for  
services requires more, not fewer, resources.3 In order to serve a growing popu-
lation of Medicaid beneficiaries—particularly those with complex and costly 
health care needs—states must find ways to maximize the impact of what funds 
are available. 
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Historically, states have attempted to contain 
costs by using policy levers that offer the most quanti-
fiable and immediate savings potential—that is, by 
lowering reimbursement rates to providers and elimi-
nating optional services and/or eligibility groups. 
Although these solutions may bring short-term relief 
from immediate budget pressures, it has been shown 
time and again that they do not lead to long-term fiscal 
sustainability. State officials and policymakers across 
the country are now recognizing that a more promising 
strategy for “bending the curve” in health care costs is 
identifying better ways to organize, finance, and 
deliver high-quality care.
As illustrated in Figure 1, “value-based” strat-
egies offer an opportunity to improve the quality of 
services while reducing growth of costs—thereby pro-
viding a compelling policy alternative to traditional 
service reductions.4 A valuable technique for supporting 
cost-effective policy decisions is return-on-investment, 
or ROI, analysis, which has been used in the private 
sector for decades to inform the allocation of limited 
resources. ROI forecasting can ensure responsible 
stewardship of taxpayer dollars in all economic cli-
mates, bad as well as good. Given the current fiscal 
challenges facing states, when resource-allocation 
decisions are under particular scrutiny, the use of tools 
like ROI analysis to support effective decision-making 
is increasingly important. ROI analysis can facilitate 
value-based purchasing in a wide range of ways, from 
aiding resource-allocation decisions and adopting evi-
dence-based, quality-improvement initiatives to identi-
fying ways that payment strategies can be aligned with 
desired performance outcomes. This issue brief outlines 
a number of Medicaid policy decisions that are ripe for 
ROI analysis.
USIng ROI TO EnhAnCE VAlUE
Policymakers seeking to develop value-driven strate-
gies for containing the growth of costs over time can 
use ROI forecasting to help identify program and 
infrastructure investments that have the potential to 
generate downstream reductions in health care and 
other state expenditures (e.g., disability payments, 
unemployment insurance). There are a number of 
opportunities for states to use ROI analyses to support 
value-based purchasing. Policy considerations that 
could benefit from such analyses include efficient allo-
cation of limited resources, adoption of evidence-based 
STEP 1:
Reimbursement Across-the-board provider rate cuts
STEP 2:
Services Eliminating optional services
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Capping enrollment
Eliminating optional groups
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To be determined as states determine that
cuts alone will not slow the rate of growth
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Figure 1. Continuum of Medicaid Cost Control Strategies
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quality-improvement initiatives, and payment reform 
to realign incentives so that they support value-based 
services. Each is considered separately below. (A list 
of specific examples of how some states have been 
using ROI forecasting to support effective policymak-
ing can be found on page 6.)
Efficient Allocation of Resources
At its most basic level, ROI forecasting allows users to 
compare the potential financial impacts of various 
resource-allocation options. In other words, where 
would states get the biggest bang for their buck? This 
type of analysis can be used to prioritize policy 
changes in the adoption, adjustment, or expansion of 
quality-improvement initiatives, as well as in broader 
benefit design decisions. 
Prioritizing among various policy options. Medicaid 
officials make decisions daily about how best to man-
age existing initiatives and whether and how new ini-
tiatives should be added to the program. Policymakers 
may be debating which clinical conditions or eligible 
population groups to target through a new quality-
improvement initiative, or which initiatives to pursue 
first. For example, a state may be considering whether 
to focus a new care-management program on benefi-
ciaries with diabetes or beneficiaries with congestive 
heart failure and thus may be interested in which pro-
gram would be more cost-effective over the next sev-
eral years. Another state may need to choose between 
launching a new medical-home initiative and expand-
ing a pay-for-performance program.
The potential ROI of each program can help 
inform which path to pursue and can provide an 
“apples-to-apples” comparison of the expected effects 
of different policy decisions. States that use ROI as 
part of their policymaking process can evaluate any 
number of options as long as the data and assumptions 
used to conduct the analyses are comparable. 
Targeting initiatives for maximum quality and cost 
impact. ROI analysis can be used to target resources 
for those population subsets that are most likely to 
benefit from improved care processes, and thus are 
most likely to generate cost savings. Given limited 
resources, a state may need to choose between “going 
broad” or “going deep.” For example, with the same 
level of program funding, the state may either target a 
broad population in a low-intensity intervention (e.g., 
all children with asthma in a telephonic care-manage-
ment program) or a smaller subset of the population in 
a high-intensity intervention (e.g., high-risk children 
with asthma in a community-based program). By ana-
lyzing the potential ROI for multiple program scenar-
ios, states can determine which interventions hold the 
greatest quality-improvement and cost-saving potential 
for which groups of beneficiaries and design their ini-
tiatives accordingly. 
Assessing the downstream effects of benefit enhance-
ments or reductions. It is a relatively straightforward 
matter to quantify the immediate cost increases or 
decreases expected to result from changes in covered 
Medicaid benefits. Using simple assumptions about 
caseloads and reimbursement rates, state budget offi-
cials commonly estimate the near-term costs associ-
ated with enhancing the benefit package to include 
new services. Likewise, state officials can readily 
quantify the dollars freed up by reducing or eliminat-
ing covered services, or by cutting provider rates. It is 
less usual, however, for them to include downstream 
service impacts (e.g., future effects on health care utili-
zation) in their financial forecasts.
For example, states often look first for cost 
reductions made possible by the elimination of optional 
services for certain beneficiaries, such as dental cover-
age for adults. While cuts to optional services often 
satisfy a need for immediate cost reductions, the cuts 
may result in longer-term cost increases in other parts 
of the system. In the case of cutting dental benefits, what 
impact on other medical or acute-care-service use should 
be expected from the likely increase in dental decay?5 
Alternatively, what happens to emergency-room (ER) 
use when physicians stop accepting Medicaid patients 
because of inadequate reimbursement rates?
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Given what we know about health care cost 
trends and previously unsuccessful efforts to contain 
Medicaid spending over time, decisions to enhance or 
reduce benefits should be made strategically, ideally 
with an eye toward more than a single budget cycle. 
States can use ROI analysis to compare which 
enhancements will provide the maximum impact on 
quality outcomes for the marginal dollar invested, and 
which cuts will have the fewest unintended effects on 
health care spending over the long term.
Creating a “portfolio” approach to program invest-
ments. Not every initiative worth pursuing will gener-
ate a positive ROI, particularly in the short run. Some 
program or infrastructure investments with potential to 
vastly improve patient care and health outcomes may 
require too long a time period for payback, or may 
never generate cost savings at all. Initiatives meant to 
promote more effective care for depression offer a 
good example of this dilemma, as evidence suggests 
that potential offsets to the costs of increased treatment 
take several years to emerge.8
To support the implementation of promising 
plans in the face of limited resources, Medicaid offi-
cials can consider using initiatives that generate a 
short-term return in order to finance those that do not, 
thereby creating a “portfolio” approach to program 
design and implementation. ROI analysis can support 
this approach, identifying the amount and time frame 
of expected costs and savings for various initiatives 
under consideration as well as examining the possibili-
ties for pairing initiatives that have shorter-term payback 
potential with ones that have longer-term potential. 
Linking two or more quality-improvement initiatives 
with ROI analyses that in total are budget-neutral may 
allow Medicaid to implement programs that would not 
otherwise have been possible.
For example, initiatives to improve care for 
high-risk asthma or high-risk pregnancy, for which 
mounting evidence suggests a positive ROI can be 
expected in one to two years, might be paired with a 
depression program, which is typically slower to show 
savings, and thus support its costs over the near term.9 
Likewise, other quality-improvement initiatives with 
cost-savings potential could be used to offset expansions 
of coverage or to avoid proposed service reductions. 
Adoption of Evidence-Based Policies
A critical attribute of ROI forecasting is the data-
driven nature of the analysis. To develop assumptions 
for an ROI forecast, Medicaid officials must examine 
historical claims data or review the scientific literature 
to identify what changes in health care spending may 
be reasonable to expect. For example, a state launch-
ing an ER diversion initiative will need to look at the 
evidence around documented outcomes for similar ini-
tiatives in order to develop accurate projections for 
decreases in ER utilization—and to identify what 
potential increases in other services (e.g., office visits) 
A Tool for Forecasting ROI
There are number of tools available to help Medicaid officials incorporate ROI forecasting into their program-
planning and other policymaking activities (Table 1). For example, the Center for Health Care Strategies (CHCS) 
developed the ROI Forecasting Calculator for Quality Initiatives (ROI Calculator)6 to help states assess the cost-
savings potential of quality-improvement programs.
The ROI Calculator, made possible through funding from the Robert Wood Johnson Foundation, is a Web-
based tool available for public use by state Medicaid agencies, health plans, and other stakeholders. Users enter 
detailed assumptions about their proposed initiatives, including target population characteristics, program costs, 
and the magnitude and timing of expected changes in health service utilization. Then, based on these assump-
tions, the ROI Calculator quantifies the increases or decreases in projected medical expenditures that may result 
from instituting the program in question, including a range of estimates based on sensitivity analysis.7
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should be considered. Using such evidence to build 
and justify key assumptions in ROI forecasts will 
likely increase the accuracy and plausibility of the pro-
jections, which are important considerations for budget 
officials, legislators, and other stakeholders whose 
approval may be necessary to support new initiatives.
In addition to justifying key assumptions, the 
data-driven nature of developing an ROI forecast has 
two other benefits. First, a review of the literature sup-
ports the implementation of evidence-based programs 
overall, as officials may decide to modify program 
design or intervention strategies based on what the evi-
dence suggests would be most effective. For example, 
whereas the ER diversion initiative mentioned above 
may be initially envisioned as a one-time counseling 
intervention, a review of the evidence may suggest 
more intensive, ongoing follow-up by nurses or case-
managers is desirable for particularly high-risk subsets 
of frequent ER users. 
Second, where the state has prior experience 
with initiatives similar to one being proposed, officials 
must carefully review their own data in order to 
develop ROI forecast assumptions. This review often 
leads to surprising findings, or interesting revelations 
about where and for which population subsets these 
programs have been more or less effective. For exam-
ple, in conducting a forecast for the continuation of a 
statewide disease-management program, officials in 
Pennsylvania found that a small subset of its beneficia-
ries with five or more co-occurring chronic illnesses 
drove a surprisingly large proportion of its total medi-
cal expenditures. This finding led the state to consider 
directing a more intense level of resources at this pop-
ulation in future versions of the program. Similarly, 
when officials from Idaho reviewed claims data to 
support their ROI forecasts, they found that where 
beneficiaries had co-occurring diabetes and mental ill-
ness there were significant gaps in the quality of health 
care delivered, which suggested ways for them to target 
more efficient use of health care resources in the future.
Although the evidence base to support 
Medicaid policy decisions is far from complete, there 
is a growing body of literature that can be used to 
inform the design and implementation of initiatives 
meant to improve access to and quality of care for 
Medicaid beneficiaries. For example, Table 2 summa-
rizes a number of published studies of asthma quality-
of-care initiatives involving Medicaid populations that 
have demonstrated cost savings. In addition, as the 
pressure to rigorously evaluate and measure the 
impacts of new initiatives continues to grow, and as 
efforts to create a platform for sharing Medicaid data 
and lessons across states intensify, the evidence base 
should expand significantly in the years ahead.
Payment Reform to Align Financial Incentives 
ROI forecasting can assist Medicaid stakeholders in 
their efforts to use payment policies as a lever for 
promoting high-quality, cost-effective care. Across the 
country, states are looking for ways to reform current 
payment systems to increase accountability among 
plans and providers and to align financial incentives 
with desired quality and cost outcomes. To support 
these reforms, ROI forecasting can:
Realign incentives to promote improvement in quality 
of care. By evaluating a program’s financial impact on 
various stakeholders across the health care system, 
states can identify where current financing mecha-
nisms may support—or act as barriers to—efforts to 
improve quality of care. For example, suppose a group 
of providers collaborates to improve chronic-disease 
care by implementing an electronic registry, which 
would require a substantial financial investment in 
technology infrastructure and staff time to support it. If 
the registry is used successfully, the collaborators’ 
effort is likely to bring about better chronic-care man-
agement for their patients, thereby avoiding and/or 
delaying preventable complications and associated 
health care expenditures down the road. ROI analysis 
may show that any financial return associated with 
such improvements in care processes may take years 
to flow to the providers themselves, whereas Medicaid 
and other payers may reap benefits in the near term 
through more efficient health care utilization among 
their beneficiaries. ROI analysis could thus support 
cross-payer efforts to contribute to the required upfront 
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investments (e.g., subsidizing the electronic registry), 
or to establish mechanisms for sharing near-term sav-
ings with providers in order to accelerate their time 
frame for recouping costs. For example, in New York 
State, a new chronic-illness demonstration program 
includes a gain-sharing pool, whereby savings gener-
ated by investments in new and improved care-man-
agement interventions will be shared with participating 
delivery systems and/or providers, based on their per-
formance on quality-of-care and cost indicators.
Analyze options for broad-scale payment reform. 
Recognizing that current service-based payment sys-
tems do not necessarily promote coordinated and high-
quality-care management, states and other payers are 
considering broad reforms to their payment systems 
(e.g., bundled payments) to support, for example, the 
concept of patient-centered medical homes.10 Ideally, 
the benefits of developing and supporting patient-cen-
tered medical homes should translate into fewer costly 
hospitalizations and more appropriate ER use. Such 
changes in patient utilization patterns should, in turn, 
ROI Forecasting: Examples from the Field12
In 2007 and 2008, Medicaid officials from eight states participated in the ROI Purchasing Institute, supported by 
The Commonwealth Fund and the Robert Wood Johnson Foundation.13 Participants piloted the use of the Center 
for Health Care Strategies ROI Calculator and received technical assistance in how to incorporate ROI forecast-
ing into the planning and monitoring of quality-of-care initiatives. The experiences of these states highlight a 
number of ways that ROI forecasting can be used to support quality-improvement efforts. As summarized in the 
examples below, ROI forecasting can:
Allocate resources and support budget requests for proposed quality initiatives.•	  Arizona used ROI 
forecasting to help determine the clinical focus for a proposed pay-for-performance initiative. Through its 
analysis, Arizona concluded that a planned focus on asthma would not have yielded a sufficient return on new 
investments because previous improvements had already been achieved in asthma care. With the program 
redefined to include diabetes, immunizations, and nursing-home care, the state was able to use estimated 
cost savings to develop a budget appropriation request for funding the incentive program.
Evaluate trade-offs associated with various program implementation options. •	 Colorado used ROI 
forecasting to examine options for expanding a pilot initiative that enrolled children in a medical home. The 
state evaluated the pilot’s ROI and estimated the cost savings that could be generated if the program were 
to be expanded statewide. Based on the anticipated savings, Colorado was able to consider enhanced 
provider reimbursement as well as the inclusion of additional populations, such as the aged and disabled, 
as beneficiaries. 
Establish realistic cost-savings expectations for programs in various stages of implementation. •	
Oklahoma used ROI forecasting to project the savings that could be achieved by treating people with diabe-
tes in the state’s newly launched Health Management Program. The projected savings helped gain the sup-
port of stakeholders during the program-development phase. Now that the program has rolled out, Oklahoma 
intends to use ROI analysis to evaluate whether or not its initial savings estimates were on target. 
Inform conversations with contracted providers of care-management services. •	 Washington State used 
ROI forecasting to develop internal projections of financial outcomes associated with its Chronic Care Management 
Program. The process of comparing these internal projections with ones provided by a partner contracted to 
provide care-management services led to increased transparency in discussions between the parties and 
improved the ability of state officials to ask the right questions and interpret the contractor’s program data.
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generate cost savings that could be used to fund bun-
dled payments to providers–including reimbursement 
to support expanded care-coordination responsibilities. 
By using ROI analysis to identify the expected down-
stream savings derived from medical-home implemen-
tation, a state can determine the size and scope of bun-
dled payments it may be able to support and decide for 
which sets or subsets of beneficiaries the concept may 
be financially sustainable. For example, analysis may 
suggest focusing initial implementation on the rela-
tively higher-cost, more complex beneficiaries where 
opportunities for both quality-of-care and cost benefits 
are more imminent. 
Support the design of integrated-care programs for 
dual-eligibles. Roughly 46 percent of Medicaid dollars 
and 25 percent of Medicare dollars are spent on the 
approximately 8.8 million adults who are eligible for 
both government programs.11 Given the significance of 
these resources, there is growing interest across states 
in designing programs that better coordinate Medicaid 
and Medicare benefits to both a) provide care to dual-
eligibles in a more integrated, person-centered, and 
resource-efficient way than at present, and b) address 
the inherent incentives for shifting costs between the 
two programs. While there is a spectrum of integration 
possible, the most promising programs integrate not 
only the Medicare and Medicaid benefits but also the 
funding streams. To support the design of integrated 
financing for duals, ROI analysis can be used to identify 
both financial misalignments and potential benefits 
expected to result from any integration, thus informing 
conversations between the Center for Medicare and 
Medicaid Services (CMS) and prospective health-plan 
partners about the programs. For example, a state 
investment in intensive-care management for duals 
could be expected to result in reduced inpatient or ER 
costs, the savings from which would accrue to 
Medicare. The state could develop an ROI forecast to 
build a case for an integrated-care demonstration that 
would allow Medicaid to benefit from a portion of  
the savings generated by its investment in care- 
management intervention.
COnClUSIOn
This is a challenging yet exciting time for health care. 
Payers, purchasers, providers, and consumers are 
actively engaged in the effort to find more effective 
means of organizing, financing, and delivering care 
throughout the system. Whether or not far-reaching 
reform comes to pass, and irrespective of how long the 
current economic downturn persists, Medicaid has a 
unique opportunity to demonstrate how health care 
quality can be improved in a cost-effective and 
resource-efficient manner. By incorporating ROI anal-
ysis into program planning and policy development, 
states can increase their capacity for strategic decision-
making and value-based purchasing. So armed, 
Medicaid will be better positioned than ever to lead 
broader health system reforms across the country. 
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Table 1. Tools for Conducting and Informing ROI Analyses
Tool Use For More Information
AHRQ Asthma  
ROI Calculator
Estimates the potential ROI for quality-improvement interventions for 
individuals with asthma, using evidence from the literature and data on 
actual asthma patients to determine disease prevalence, cost of care, 
and service utilization in this population. 
www.academyhealth.org/ahrq/quality-
tools/AsthmaROISummary.pdf
CDC Chronic-Disease 
Cost Calculator
Estimates the state Medicaid expenditures for beneficiaries with any of 
six chronic diseases (congestive heart failure, heart disease, stroke,  
hypertension, cancer, and diabetes). Generates the estimates using 
customized inputs (e.g., state-level prevalence rates and treatment 
costs). Can in the absence of program-level utilization and prevalence 
data on these populations provide a reasonable proxy for costs and 
prevalence for use in ROI analysis. 
www.cdc.gov/nccdphp/resources/
calculator.htm
CHCS ROI  
Forecasting 
Calculator for  
Quality Initiatives
Estimates the potential ROI from quality-improvement initiatives in 
Medicaid. Quantifies potential savings when states, health plans, and 
other payers enter assumptions about target population characteristics, 
program costs, and expected changes in health care utilization in the 
calculator. Incorporates an ROI Evidence Base that includes data from 
published studies of quality-improvement initiatives focused on asthma, 
congestive heart failure, diabetes, and high-risk pregnancy. 
www.chcsroi.org 
CHCS  
ROI Template
Calculates the actual ROI achieved by quality initiatives post-implemen-
tation. Includes detailed templates for capturing investment costs asso-
ciated with developing and implementing quality initiatives.
http://www.chcs.org/publications3960/
publications_show.htm?doc_
id=702936 
Leapfrog  
ROI Estimator
Estimates the potential ROI from implementation of the Leapfrog Hos-
pital Rewards Program. Analyzes both the clinical and cost effects of 
implementing this pay-for-performance program. 
http://roiestimator.com/
NCQA Quality  
Dividend Calculator
Estimates the potential ROI to employers from providing employees 
with access to higher-quality health care, the potential ROI to be based 
on improved productivity and reduced absenteeism.
www.ncqacalculator.com 
Table 2. Examples of Randomized Studies of Asthma Care Interventions14
Study Intervention Strategies Evaluation Timeframe
Cost/Utilization 
Outcomes
M. Castro et al., American Journal of 
Respiratory & Critical Care Medicine, 
Nov. 1, 2003 168(9):1095–99
Use of asthma nurse specialist in hospital to provide 
guideline-based recommendations to physicians as 
well as self-management education, psychosocial 
support, and follow-up care to patients
12 mos. 67% decrease in asthma-
related hospital costs
Z. Harish et al., Annals of Allergy, 
Asthma, & Immunology, Feb. 2001 
86(2):185–89
Use of specialty clinic to provide intensive medical 
and environmental control of condition, education and 
close monitoring of patients, and 24-hour availability 
of care
24 mos. 69% reduction in Year 1 ER 
visits; 60 percent reduction in 
Year 2 ER visits
M. Kattan et al. Pediatrics, June 2006 
117(6):e1095–e1103
Use of patient feedback letters to providers combined 
with guideline-based recommendations for changes 
in therapy
12 mos. 24% reduction in ER visits
S. Krishna et al., Pediatrics, March 2003 
111(3):503–10
Use of internet-enabled interactive multimedia asthma 
education program by participants in exam room and 
waiting rooms during clinic visits
12 mos. 68% reduction in ER visits
S. J. Teach et al., Archives of Pediat-
rics & Adolescent Medicine, May 2006 
160(5):535–41
Use of specialized, ER-based clinic following an ER 
visit for asthma, with clinic providing assessment and 
education in asthma self-management and environ-
mental triggers as well as linkages and referrals to 
ongoing care
6 mos. 46% reduction in ER visits  
for asthma
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